Get the Stockscreener App
2.75
8.03%
-0.24
After Hours:
2.78
0.03
+1.09%
Evaxion Biotech A S Adr Stock (EVAX) Latest News
Top investors say Evaxion Biotech A/S ADR (EVAX) ticks everything they need - SETE News
Evaxion Biotech A/S ADR [EVAX] Investment Guide: What You Need to Know - Knox Daily
Evaxion Biotech A/S ADR (EVAX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Palantir Technologies Surges 16.5% in Pre-Market Trading After Strong Q4 Earnings Report - HPBL
Evaxion Biotech (EVAX) Stock Analysis: Price Decline, Analyst Ratings and Financial Ratios – market - HPBL
Evaxion Biotech A/S ADR (EVAX) Receives Upgrades Amid Sharp Decline – Is It Time for Investors to Reevaluate? - HPBL
Spyre Therapeutics Inc (SYRE) stock analysis: A comprehensive overview - US Post News
Argo Blockchain Plc ADR (ARBK)’s stock price in review: A technical analysis - US Post News
Evaxion Biotech A/S ADR (EVAX)’s stock decline to 2.40 per share - US Post News
Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex
In the Green: Evaxion Biotech A/S ADR (EVAX) Closes at 2.40, Up/Down -2.24 from Previous Day - The Dwinnex
Market Insights: Kairos Pharma Ltd (KAPA)’s Notable Gain of 6.29, Closing at 1.52 - The Dwinnex
Palantir Technologies at a Crossroads: Sky-High Valuation or Looming Market Correction? - HPBL
Hodges Capital Management Takes $16.5 Million Stake in Palantir Technologies (PLTR) – market - HPBL
Major Pharma Giant's VC Fund Doubles Down on Evaxion Biotech in $10.8M Strategic Round - StockTitan
Evaxion Biotech stock hits 52-week low at $2.38 amid market challenges - Investing.com
Evaxion announces pricing of $10.8 million public offering - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $3.06 amid sharp decline By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $3.06 amid sharp decline - Investing.com
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.81 amid market challenges - Investing.com India
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Evaxion Biotech Announces 1:5 ADS Ratio Change, Effective January 2025 - StockTitan
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN
European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN
European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.84 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - MSN
European Equities Traded in the US as American Depositary Fall in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $0.92 - Investing.com
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week - MSN
European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN
Evaxion achieves preclinical success with AI cancer vaccine - Investing.com
Evaxion Biotech stock hits 52-week low at $1.19 - Investing.com
Evaxion Biotech Unveils Ambitious 2025 Roadmap: AI-Powered Vaccines, $10M Deal Potential, Clinical Milestones - StockTitan
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech stock hits 52-week low at $1.31 By Investing.com - Investing.com South Africa
Evaxion Biotech stock hits 52-week low at $1.31 - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):